Literature DB >> 2373138

High-density lipoprotein subfractions, apolipoproteins and antipyrine clearance in normal subjects.

P V Luoma1, A Rautio, J Stengård, E A Sotaniemi, J Marniemi.   

Abstract

Serum high density lipoprotein (HDL) subfractions HDL2 and HDL3, apolipoproteins, and plasma antipyrine clearance (AP-CL) rate, an index of liver microsomal enzyme activity, were determined in 21 healthy subjects. High HDL cholesterol and HDL2 cholesterol concentrations and HDL cholesterol/cholesterol and HDL2/HDL3 cholesterol ratios were associated with high AP-CL. Phenobarbital enhanced antipyrine elimination and increased the apolipoprotein A-I/A-II ratio. Subjects who had high AP-CL had a more antiatherogenic HDL subfraction and apolipoprotein profile than those with low AP-CL.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373138     DOI: 10.1007/bf00278594

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Influence of some factors on development of experimental cholesterol atherosclerosis.

Authors:  A L MYASNIKOV
Journal:  Circulation       Date:  1958-01       Impact factor: 29.690

2.  Effect of phenobarbital and chlorcyclizine on the development of atheromatosis in the cholesterol-fed rabbit.

Authors:  R A Salvador; C Atkins; S Haber; C Kozma; A H Conney
Journal:  Biochem Pharmacol       Date:  1970-06       Impact factor: 5.858

3.  The association of serum lipids, lipoproteins, and apolipoproteins with coronary artery disease assessed by coronary arteriography.

Authors:  H K Naito
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

4.  Mortality and cholesterol metabolism in familial hypercholesterolemia. Long-term follow-up of 96 patients.

Authors:  T A Miettinen; H Gylling
Journal:  Arteriosclerosis       Date:  1988 Mar-Apr

5.  Discriminative value of lipids and apoproteins in coronary heart disease.

Authors:  G De Backer; M Rosseneu; J P Deslypere
Journal:  Atherosclerosis       Date:  1982-04       Impact factor: 5.162

6.  Elevated serum cholesterol in drug-oxidation-deficient rats.

Authors:  H H Nadir; S G Al-Dabbagh; J R Idle
Journal:  Biochem Pharmacol       Date:  1982-04-15       Impact factor: 5.858

Review 7.  Microsomal enzyme induction, lipoproteins and atherosclerosis.

Authors:  P V Luoma
Journal:  Pharmacol Toxicol       Date:  1988-05

8.  Serum selenium, glutathione peroxidase, lipids, and human liver microsomal enzyme activity : A double-blind controlled trial of selenium supplementation.

Authors:  P V Luoma; H Korpela; E A Sotaniemi; J Kumpulainen
Journal:  Biol Trace Elem Res       Date:  1985-09       Impact factor: 3.738

9.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

10.  Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study.

Authors:  A Muuronen; M Kaste; E A Nikkilä; E M Tolppanen
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-23
View more
  2 in total

Review 1.  Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementia.

Authors:  P V Luoma
Journal:  Curr Mol Med       Date:  2011-07       Impact factor: 2.222

Review 2.  Elimination of endoplasmic reticulum stress and cardiovascular, type 2 diabetic, and other metabolic diseases.

Authors:  Pauli V Luoma
Journal:  Ann Med       Date:  2012-08-28       Impact factor: 4.709

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.